The landscape of dementia prognosis has progressed substantially with the appearance of advanced biomarkers, like amyloid PET scans, tau imaging, and blood-centered checks that may detect Alzheimer's pathology several years in advance of indications arise. Whilst these technological developments symbolize amazing development in knowledge neurodegen